Literature DB >> 20637991

Idiopathic intracranial hypertension.

Michael Wall1.   

Abstract

Idiopathic intracranial hypertension ((IIH) is characterized by increased cerebrospinal fluid pressure of unknown cause. It is predominantly a disease of women in the childbearing years. Although the cause of IIH remains obscure, it has become clear that loss of visual function is common and patients may progress to blindness if untreated. Diagnosis should adhere to the modified Dandy criteria and other causes of intracranial hypertension sought. IIH patient management should include serial perimetry and optic disc grading or photography. The proper therapy can then be selected and visual loss prevented or reversed. Although there are no evidence-based data to guide therapy, there is an ongoing randomized double-blind controlled treatment trial of IIH investigating diet and medical therapy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20637991      PMCID: PMC2908600          DOI: 10.1016/j.ncl.2010.03.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  96 in total

1.  Benign intracranial hypertension. II. Following corticosteroid therapy.

Authors:  M GREER
Journal:  Neurology       Date:  1963-05       Impact factor: 9.910

2.  Brain swelling of unknown cause.

Authors:  R J JOYNT; A L SAHS
Journal:  Neurology       Date:  1956-11       Impact factor: 9.910

3.  Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome.

Authors:  G S Cinciripini; S Donahue; M S Borchert
Journal:  Am J Ophthalmol       Date:  1999-02       Impact factor: 5.258

4.  Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver.

Authors:  Lawrence Neville; Robert A Egan
Journal:  Can J Ophthalmol       Date:  2005-12       Impact factor: 1.882

5.  Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002.

Authors:  William T Curry; William E Butler; Fred G Barker
Journal:  Neurosurgery       Date:  2005-07       Impact factor: 4.654

Review 6.  Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension.

Authors:  Deborah I Friedman
Journal:  J Neuroophthalmol       Date:  2006-03       Impact factor: 3.042

7.  Papilledema associated with increased intracranial pressure in Addison's disease.

Authors:  F B WALSH
Journal:  AMA Arch Ophthalmol       Date:  1952-01

8.  The use of acetazolamide in idiopathic intracranial hypertension during pregnancy.

Authors:  Andrew G Lee; Misha Pless; Julie Falardeau; Tammy Capozzoli; Michael Wall; Randy H Kardon
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

9.  Gastric surgery for pseudotumor cerebri associated with severe obesity.

Authors:  H J Sugerman; W L Felton; A Sismanis; J M Kellum; E J DeMaria; E L Sugerman
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

10.  Idiopathic intracranial hypertension: relation of age and obesity in children.

Authors:  L J Balcer; G T Liu; S Forman; K Pun; N J Volpe; S L Galetta; M G Maguire
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

View more
  74 in total

Review 1.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

2.  Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review.

Authors:  Jason T Chisholm; Michelle M Abou-Jaoude; Amy B Hessler; Padmaja Sudhakar
Journal:  Neuroophthalmology       Date:  2017-09-01

3.  [Pseudotumor cerebri syndrome].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

4.  Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.

Authors:  J Libien; M J Kupersmith; W Blaner; M P McDermott; S Gao; Y Liu; J Corbett; M Wall
Journal:  J Neurol Sci       Date:  2016-11-10       Impact factor: 3.181

Review 5.  Pain in optic neuropathies.

Authors:  Stefania Bianchi Marzoli; Alessandra Criscuoli
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 6. 

Authors:  Vincent Wu; Bonnie Cooke; Susan Eitutis; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2018-07       Impact factor: 3.275

Review 7.  Update on the pathophysiology and management of idiopathic intracranial hypertension.

Authors:  Valérie Biousse; Beau B Bruce; Nancy J Newman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-03-15       Impact factor: 10.154

8.  Neuroimaging Features of Idiopathic Intracranial Hypertension Persist After Resolution of Papilloedema.

Authors:  Randy O Chang; Brigid K Marshall; Noushin Yahyavi; Aseem Sharma; Julia Huecker; Mae O Gordon; Collin McClelland; Gregory P Van Stavern
Journal:  Neuroophthalmology       Date:  2016-05-27

9.  Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity.

Authors:  Khin P Kilgore; Michael S Lee; Jacqueline A Leavitt; Bahram Mokri; David O Hodge; Ryan D Frank; John J Chen
Journal:  Ophthalmology       Date:  2017-02-07       Impact factor: 12.079

Review 10.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.